Hormone receptor positive breast cancer – Life with Disease

Go back

Hormone receptor positive breast cancer is a type of breast cancer where the cells have special proteins that allow hormones in the body to fuel the cancer’s growth, but this same characteristic also makes it responsive to treatments that can block or reduce these hormones.

Understanding the Prognosis

Learning about the outlook after a diagnosis of hormone receptor positive breast cancer can feel overwhelming, but understanding what to expect can help you and your loved ones prepare for the journey ahead. The prognosis for this type of breast cancer is often more encouraging than for many other forms of the disease, partly because there are targeted treatments available that work specifically against the hormones driving the cancer’s growth[1].

The outlook depends on many factors, including the stage at which the cancer is found, whether it has spread to other parts of the body, and how well the cancer responds to treatment. If hormone receptor positive breast cancer—meaning cancer that uses hormones like estrogen or progesterone to grow—is detected early, there are more treatment options available and a better chance for survival[14]. Research shows that the five-year survival rate for localized, early-stage breast cancer is now 99 percent[17].

About 70 to 80 percent of all breast cancers in women are estrogen receptor positive, abbreviated as ER-positive[2][3]. This means the cancer cells contain proteins called estrogen receptors that become activated when the hormone estrogen binds to them, causing the cells to grow. Many of these cancers are also progesterone receptor positive, or PR-positive, meaning they respond to the hormone progesterone as well[1].

The good news is that hormone receptor positive breast cancers tend to grow more slowly than hormone receptor negative cancers[3]. This slower growth pattern often gives patients and doctors more time to develop and adjust treatment plans. Most people with ER-positive breast cancer are also PR-positive, and this combination often responds well to hormone therapy treatments that block the effects of these hormones or reduce their levels in the body[2].

However, it’s important to understand that approximately 25 percent of patients with early-stage breast cancer will eventually experience distant metastasis—meaning the cancer spreads to other parts of the body[16]. This highlights why ongoing monitoring and adherence to recommended treatments are so crucial, even when initial treatment appears successful.

⚠️ Important
If breast cancer returns or spreads to other areas of the body, your hormone receptor status can change. For example, if the first tumor was treated with hormone therapies, a cancer that returns may become resistant to that therapy. In other cases, a tumor may undergo changes to gain or lose hormone receptor presence. That’s why doctors may recommend retesting the cancer’s biomarkers if it comes back or progresses[3][15].

How the Disease Progresses Naturally

Without treatment, hormone receptor positive breast cancer follows a pattern driven by the body’s own hormones. When cancer cells have estrogen receptors, progesterone receptors, or both, these cells essentially feed on the hormones circulating naturally in your body. Every time estrogen or progesterone attaches to these receptors on the cancer cells, it sends a signal telling the cells to divide and multiply[3][4].

In premenopausal women, the ovaries are the main source of estrogen. Even after menopause, however, estrogen continues to be produced by other tissues in the body, including fat and skin cells, in both women and men[2]. This means that even postmenopausal women and men with hormone receptor positive breast cancer can experience ongoing cancer growth if left untreated.

The natural progression typically begins with abnormal cells growing in the breast tissue. As these cells continue to receive hormonal signals to grow, they can form a lump or tumor. Over time, if the cancer is not detected and treated, it may spread beyond the breast tissue. The cancer can move into nearby lymph nodes—small, bean-shaped organs that are part of the immune system—and from there, potentially to other parts of the body such as the bones, liver, lungs, or brain[6].

The speed at which this happens varies considerably from person to person. Hormone receptor positive breast cancers generally grow more slowly than hormone receptor negative types[3]. This slower growth is one reason why these cancers often have a better prognosis when caught early. However, without intervention, even slow-growing cancers will eventually progress and become more difficult to treat.

Possible Complications

Living with hormone receptor positive breast cancer means being aware of potential complications that can arise both from the disease itself and from its treatments. Understanding these possibilities can help you recognize warning signs early and seek appropriate medical attention.

One significant complication is the development of treatment resistance. Some cancers that initially respond well to hormone therapy may eventually become resistant to these treatments[3]. This happens when cancer cells find ways to grow without needing the hormones that once fueled them, or when they develop mutations that allow them to bypass the blocking effects of hormone therapy drugs.

Another major concern is recurrence—when breast cancer comes back after treatment. Recurrence can happen in the same breast, in nearby tissue, or in distant parts of the body. Women who gain weight during or after breast cancer treatment have been consistently shown to be at higher risk of breast cancer-related death[16]. Similarly, women who are overweight or obese at the time of diagnosis tend to have a poorer prognosis[16].

The mechanisms by which obesity might affect breast cancer outcomes include a rise in circulating insulin-like growth factor, elevated circulating sex hormones, and production of inflammatory substances called cytokines that can promote cancer growth[16]. Metabolic syndrome—a cluster of conditions including high blood pressure, elevated blood sugar, excess body fat around the waist, and abnormal cholesterol levels—may also play a role[16].

Treatment-related complications deserve attention as well. Hormone therapy, which is the standard treatment for hormone receptor positive breast cancer, can cause side effects that significantly impact quality of life. These include hot flashes, bone and joint pain, vaginal dryness, brain fog, and bone thinning in younger women[17]. While these side effects are not the same for everyone—some people rarely experience them while others find they disturb their daily life considerably—they are common enough that many patients consider stopping treatment early.

This decision to discontinue hormone therapy due to side effects is itself a complication, because it increases the risk of cancer recurrence. Doctors typically recommend taking hormone therapy for five to ten years, depending on the risk of cancer coming back[17]. Research has shown that extending tamoxifen treatment to ten years further reduces the risk of recurrence compared to stopping at five years[11][12].

Some patients may develop osteoporosis or severe bone thinning (called osteopenia) as a result of hormone therapy, particularly with drugs called aromatase inhibitors[17]. This makes bones more fragile and increases the risk of fractures from minor falls or injuries.

Impact on Daily Life

A diagnosis of hormone receptor positive breast cancer affects nearly every aspect of daily living. The physical, emotional, social, and practical challenges can be profound, and understanding how others have navigated these changes may help you prepare for your own journey.

Physically, treatment side effects can make even routine activities more challenging. Many women experience fatigue, which is a major issue for people going through chemotherapy and radiation[14]. This isn’t ordinary tiredness—it’s a deep exhaustion that doesn’t improve with rest and can make it difficult to work, care for your family, or enjoy hobbies and social activities.

Approximately 30 to 40 percent of people who receive certain chemotherapy drugs develop peripheral neuropathy, a condition that causes tingling, burning, weakness, or numbness in the hands and feet[14]. Imagine trying to button your shirt, type on a computer, or walk steadily when your fingertips or feet feel numb or painfully tingly. For some people, this neuropathy lessens over time, but for others, it becomes a long-term challenge[14].

Brain fog—difficulty concentrating, remembering things, or thinking clearly—can linger for months after chemotherapy[14]. This can affect your performance at work, your ability to manage household responsibilities, and even simple conversations with friends.

Because most breast cancers are estrogen receptor positive, many patients are prescribed anti-estrogen therapy as part of their treatment. Some people have no symptoms with this therapy, while others experience menopause-like symptoms including hot flashes, vaginal dryness, and joint aches[14]. Hot flashes can strike suddenly, leaving you drenched in sweat during important meetings or social events. Vaginal dryness can affect intimate relationships with your partner. Joint pain can make it difficult to exercise, climb stairs, or even get out of bed in the morning.

The emotional and psychological impact can be equally challenging. The feeling of loss of control is one of the biggest challenges of a cancer diagnosis[16]. You may feel anxious about the future, worried about recurrence, or depressed about changes to your body and lifestyle. Many breast cancer survivors share the need for emotional support[14].

Social relationships may shift in unexpected ways. Some friends may not know what to say or how to help, and may pull away just when you need them most. Others may offer support but in ways that feel overwhelming or unhelpful. Work relationships can become complicated if you need to take time off for treatments or if side effects affect your performance.

Family dynamics often change as well. If you have been the primary caregiver in your family, accepting help from others—including your children—can feel uncomfortable or even distressing. Partners may struggle with their own fear and anxiety about your diagnosis while trying to provide support to you.

Financial concerns add another layer of stress. Medical bills can accumulate quickly, and if treatment side effects force you to reduce your work hours or stop working entirely, loss of income can create significant hardship.

Despite these challenges, many patients find that making positive lifestyle changes can be psychologically beneficial by empowering them and helping them feel more in control[16]. Research shows that exercise is a key component for extending cancer survivorship and managing side effects[17]. This can range from vigorous activities like running to gentle practices like yoga, tai chi, strength training, or walking[17].

Managing diet and maintaining a healthy weight are also important. Eating a healthy diet that is high in fiber and low in saturated fats, being physically active, maintaining a healthy weight, and limiting alcohol may reduce the risk of breast cancer recurrence[18][19].

⚠️ Important
Patients interested in herbal supplements, vitamins, energy drinks, protein powders, or other non-regulated “health” products should speak with their doctors before using them. Some products can interact with cancer treatment or cause other health problems[17]. There is no need to suffer silently through the side effects of breast cancer treatment—talk to your healthcare professional about what you can do to relieve your symptoms[14].

Support for Family Members

When someone you love is diagnosed with hormone receptor positive breast cancer, you may feel helpless, scared, or uncertain about how to help. Understanding what families should know—particularly about clinical trials and research opportunities—can help you become a more effective support person during this challenging time.

Family members and friends play a vital role in supporting breast cancer patients. Research consistently shows that having strong social support improves outcomes and quality of life. However, knowing specifically how to help isn’t always obvious. One important way you can assist is by helping your loved one learn about and potentially participate in clinical trials.

Clinical trials are research studies that test new treatments or new ways of using existing treatments. For hormone receptor positive breast cancer, these trials might investigate new hormone therapy drugs, combinations of treatments, or strategies to reduce side effects. Participating in a clinical trial can give patients access to cutting-edge treatments that aren’t yet available to the general public, while also contributing to medical knowledge that will help future patients.

As a family member, you can help by researching clinical trial options that might be appropriate for your loved one. Many reputable websites maintain databases of ongoing trials. When you find potentially relevant trials, you can help your family member understand what each trial involves, including the potential benefits and risks, the time commitment required, and whether the trial location is accessible.

Preparing for clinical trial participation involves several steps where family support is invaluable. First, help gather all relevant medical records, test results, and pathology reports. These documents will be needed to determine whether your loved one is eligible for specific trials. Organizing these records into a clear, accessible file can save time and reduce stress.

Accompany your family member to appointments with their oncologist to discuss clinical trial options. Having another person present during these conversations is helpful because medical information can be overwhelming, and it’s easy to forget questions or miss important details when you’re anxious. Take notes during the appointment, write down any medical terms you don’t understand, and don’t be afraid to ask the doctor to explain things more clearly or repeat information.

If your loved one decides to pursue a clinical trial, help them prepare questions to ask the research team. Important questions include: What is the purpose of this trial? What treatments or procedures are involved? What are the possible side effects? How long will the trial last? Will there be additional costs? What happens if the treatment doesn’t work or causes problems?

Beyond clinical trials, family members can provide crucial practical and emotional support. Offer specific help rather than saying “let me know if you need anything,” which puts the burden on the patient to ask. Instead, say things like “I’m going to the grocery store on Tuesday—what can I pick up for you?” or “I’d like to drive you to your treatment appointment on Thursday.”

Learn about your loved one’s specific treatment plan and expected side effects so you can anticipate needs. If they’re starting hormone therapy, understand that they might experience hot flashes, joint pain, or mood changes, and be patient and supportive when these occur. If they’re having surgery, know what physical limitations they might face during recovery and be ready to help with tasks like cooking, cleaning, or childcare.

Take care of your own emotional health as well. Supporting someone with cancer is exhausting and emotionally draining. Seek your own support through counseling, support groups for caregivers, or talking with trusted friends. You cannot pour from an empty cup—maintaining your own wellbeing enables you to provide better support to your loved one.

Listen without trying to fix everything. Sometimes patients need to express fear, anger, or sadness, and they need someone who will simply listen without judgment or trying to make them feel better. Resist the urge to say things like “stay positive” or “everything happens for a reason,” which can feel dismissive of their very real and valid feelings.

Respect your loved one’s choices about their treatment and care. They may make decisions you don’t agree with or wouldn’t make yourself, but ultimately it’s their body and their life. Offer information and support, but allow them to maintain control over their medical decisions. This sense of control is particularly important given that the feeling of loss of control is one of the biggest challenges of a cancer diagnosis[16].

💊 Registered drugs used for this disease

List of officially registered medicines that are used in the treatment of this condition, based only on the provided sources:

  • Tamoxifen – A selective estrogen receptor modulator (SERM) that blocks estrogen receptors on breast cancer cells, preventing estrogen from promoting cancer growth. Commonly used as adjuvant therapy to reduce recurrence risk.
  • Toremifene – Another selective estrogen receptor modulator (SERM) that works similarly to tamoxifen by blocking estrogen’s effects on breast cancer cells.
  • Fulvestrant – A selective estrogen receptor downregulator (SERD) that not only blocks but also degrades estrogen receptors, especially useful in advanced breast cancer treatment alone or in combination with other therapies.
  • Anastrozole – A third-generation aromatase inhibitor that stops the production of estrogen in the body by blocking the aromatase enzyme, used particularly in postmenopausal women.
  • Letrozole – A third-generation aromatase inhibitor that reduces estrogen production and has been shown to be superior to tamoxifen in certain settings.
  • Exemestane – A steroidal aromatase inhibitor that permanently blocks the aromatase enzyme, reducing estrogen levels in the body.
  • Palbociclib – A cyclin-dependent kinase 4/6 inhibitor used in combination with hormone therapy for advanced hormone receptor positive breast cancer.

Ongoing Clinical Trials on Hormone receptor positive breast cancer

  • Study on Cannabidiol for Joint Pain in Early Breast Cancer Patients on Hormone Therapy

    Not yet recruiting

    3 1
    Investigated drugs:
    France
  • Gedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy

    Not recruiting

    3 1 1 1
    Austria Belgium Bulgaria Czechia France Germany +6
  • Study of Fadraciclib in Adults with Advanced Solid Tumors (Including Breast, Colorectal, Endometrial, Ovarian, Biliary Tract, and Liver Cancer) and Lymphoma

    Not recruiting

    1 1 1
    Investigated drugs:
    Spain
  • Study on Diarrhea Discontinuations in Early-stage HER2+ Breast Cancer Patients Treated with Neratinib, Loperamide, and Colesevelam

    Not recruiting

    2 1 1 1
    Croatia France Italy Spain
  • Study of Capivasertib and Fulvestrant for Patients with Advanced or Metastatic HR+/HER2- Breast Cancer

    Not recruiting

    3 1 1
    Investigated drugs:
    Belgium France Germany Hungary Italy Poland +1
  • Study of palbociclib with hormone therapy versus hormone therapy alone in patients with recurrent hormone receptor-positive/HER2-negative breast cancer after surgery

    Not recruiting

    3 1 1 1
    Investigated drugs:
    Austria France Hungary Italy Spain
  • Study of JK08, Pembrolizumab, and Lenvatinib for Patients with Advanced or Metastatic Cancer

    Not recruiting

    2 1 1 1
    Belgium Spain
  • Study to Improve Tolerance of Sacituzumab Govitecan with Loperamide and Filgrastim in Patients with Advanced Triple-Negative or Luminal Breast Cancer

    Not recruiting

    2 1 1 1
    Spain
  • Comparing inavolisib plus fulvestrant versus alpelisib plus fulvestrant in patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation

    Not recruiting

    3 1 1 1
    Belgium France Germany Italy Poland Spain
  • Study Comparing Sacituzumab Govitecan with Other Treatments for Patients with HR+/HER2- Metastatic Breast Cancer After Endocrine Therapy

    Not recruiting

    3 1 1 1
    Austria Belgium Czechia France Germany Greece +5

References

https://breastcancernow.org/about-breast-cancer/diagnosis/hormone-receptors-and-breast-cancer

https://www.cancer.gov/types/breast/breast-hormone-therapy-fact-sheet

https://www.komen.org/blog/know-more-hr-positive-breast-cancer/

https://www.bcrf.org/about-breast-cancer/breast-cancer-hormone-receptor-status/

https://pmc.ncbi.nlm.nih.gov/articles/PMC11012464/

https://www.bmc.org/patient-care/conditions-we-treat/db/hormone-positive-breast-cancer

https://www.news-medical.net/health/Hormone-Receptor-Positive-Breast-Cancer.aspx

https://www.tgh.org/institutes-and-services/conditions/er-pr-positive-breast-cancer

https://my.clevelandclinic.org/health/diseases/er-positive-breast-cancer

https://www.cancer.gov/types/breast/breast-hormone-therapy-fact-sheet

https://www.breastcancer.org/treatment/hormonal-therapy

https://pmc.ncbi.nlm.nih.gov/articles/PMC4549764/

https://www.oncolink.org/cancers/breast/screening-diagnosis/hormone-receptor-hr-positive-breast-cancer

https://cancerblog.mayoclinic.org/2022/10/19/4-things-you-can-do-to-improve-your-quality-of-life-after-breast-cancer/

https://www.komen.org/blog/know-more-hr-positive-breast-cancer/

https://pmc.ncbi.nlm.nih.gov/articles/PMC5318212/

https://www.urmc.rochester.edu/news/story/five-things-to-reduce-side-effects-from-most-common-breast-cancer-treatment

https://breastcancernow.org/about-breast-cancer/life-after-treatment/diet-lifestyle-and-breast-cancer-recurrence

https://www.bcrf.org/about-breast-cancer/breast-cancer-prevention-risk-reduction/

https://my.clevelandclinic.org/health/diseases/er-positive-breast-cancer

https://www.nationalbreastcancer.org/breast-cancer-hormone-therapy/

FAQ

What does it mean if my breast cancer is hormone receptor positive?

It means your breast cancer cells have proteins called hormone receptors that respond to estrogen and/or progesterone. When these hormones attach to the receptors, they cause the cancer cells to grow. The good news is that this makes your cancer responsive to hormone therapy treatments that can block these hormones or reduce their levels in your body.

How long will I need to take hormone therapy?

Doctors typically recommend taking hormone therapy for 5 to 10 years, depending on your risk of cancer recurrence. Research shows that extending treatment to 10 years can further reduce the risk of the cancer coming back compared to stopping at 5 years. This is remarkably effective treatment, though it can be challenging to stick with due to side effects.

Can my hormone receptor status change over time?

Yes, if breast cancer returns or spreads, your hormone receptor status can change. For example, if the first tumor was treated with hormone therapies, a returning cancer may become resistant to that therapy. In other cases, a tumor may undergo changes to gain or lose hormone receptor presence. That’s why doctors may recommend retesting the cancer’s biomarkers if it comes back or progresses.

What can I do to reduce my risk of breast cancer coming back?

Research suggests several lifestyle changes may help reduce recurrence risk: eating a healthy diet high in fiber and low in saturated fats, being physically active, maintaining a healthy weight, and limiting alcohol consumption. Women who gain weight during or after treatment have been shown to be at higher risk of breast cancer-related death, so weight management is particularly important.

Are there ways to manage the side effects of hormone therapy?

Yes, there are many strategies to manage side effects. For hot flashes, certain medications like SSRIs can help. For vaginal dryness, lubricants and topical estrogens may provide relief. Exercise has been shown to be key for managing many side effects including fatigue, joint pain, and mood changes. Mindfulness practices like meditation and yoga can help with anxiety and depression. Acupuncture may help with pain, hot flashes, and joint discomfort. Talk to your healthcare provider about which options are right for you.

🎯 Key takeaways

  • About 70-80% of breast cancers are hormone receptor positive, making it the most common type of breast cancer, and fortunately it often responds well to targeted hormone therapy treatments.
  • The five-year survival rate for localized, early-stage hormone receptor positive breast cancer is now 99%, highlighting the importance of early detection and treatment.
  • Your hormone receptor status can change if cancer returns or spreads, which is why doctors may recommend retesting—cancer that was once responsive to hormone therapy might develop resistance.
  • Taking hormone therapy for the full recommended duration of 5-10 years is crucial, even though side effects can be challenging—extending treatment to 10 years further reduces recurrence risk.
  • Weight management is particularly important for hormone receptor positive breast cancer—women who gain weight during or after treatment have consistently been shown to be at higher risk of cancer-related death.
  • Exercise is a powerful tool that can help extend cancer survivorship, manage treatment side effects, and improve quality of life, ranging from vigorous activities to gentle practices like yoga.
  • There are many effective ways to manage hormone therapy side effects—from medications and lifestyle changes to mindfulness practices and acupuncture—so you don’t have to suffer silently.
  • Making positive lifestyle changes not only may improve your prognosis but can also be psychologically beneficial by empowering you and helping restore a sense of control during a challenging time.